Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Other Non-Current Assets (2016 - 2020)

Historic Other Non-Current Assets for Larimar Therapeutics (LRMR) over the last 8 years, with Q3 2020 value amounting to $1.3 million.

  • Larimar Therapeutics' Other Non-Current Assets changed 0.0% to $1.3 million in Q3 2020 from the same period last year, while for Sep 2020 it was $1.3 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $90000.0 for FY2019, which is 5789.47% up from last year.
  • Per Larimar Therapeutics' latest filing, its Other Non-Current Assets stood at $1.3 million for Q3 2020, which was down 0.0% from $1.3 million recorded in Q2 2020.
  • Larimar Therapeutics' 5-year Other Non-Current Assets high stood at $1.3 million for Q1 2019, and its period low was $57000.0 during Q3 2017.
  • For the 5-year period, Larimar Therapeutics' Other Non-Current Assets averaged around $488421.1, with its median value being $90000.0 (2016).
  • As far as peak fluctuations go, Larimar Therapeutics' Other Non-Current Assets tumbled by 3510.64% in 2016, and later surged by 224912.28% in 2019.
  • Quarter analysis of 5 years shows Larimar Therapeutics' Other Non-Current Assets stood at $61000.0 in 2016, then dropped by 6.56% to $57000.0 in 2017, then changed by 0.0% to $57000.0 in 2018, then skyrocketed by 57.89% to $90000.0 in 2019, then soared by 1387.78% to $1.3 million in 2020.
  • Its last three reported values are $1.3 million in Q3 2020, $1.3 million for Q2 2020, and $1.3 million during Q1 2020.